共 50 条
- [31] Development of GD2 and CD3 Targeted Bispecific T-Cell Engaging Antibodies for NeuroblastomaPEDIATRIC BLOOD & CANCER, 2017, 64 : S136 - S137Patel, A.Thevanesan, C.Anderson, J.Pule, M.Straathof, K.
- [32] CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR EQUINE HOMOLOGS OF CD3 AND CD5IMMUNOLOGY, 1994, 82 (04) : 548 - 554BLANCHARDCHANNELL, MMOORE, PFSTOTT, JL
- [33] A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodiesSCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (525)Skokos, DimitrisWaite, Janelle C.Haber, LauricCrawford, AlisonHermann, AynurUllman, EricaSlim, RabihGodin, StephenAjithdoss, DharaniYe, XuanWang, BeiWu, QiRamos, IlyssaPawashe, ArpitaCanova, LaurenVazzana, KristinRam, PriyankaHerlihy, EvanAhmed, HassanOswald, ErinGolubov, JacquelynnPoon, PatrickHavel, LaurenChiu, DanicaLazo, MiguelProvoncha, KathleenYu, KevinKim, JulieWarsaw, Jacqueline J.Oristian, Nicole StokesSiao, Chia-JenDudgeon, DrewHuang, TammyPotocky, TerraMartin, JoelMacDonald, DouglasOyejide, AdelekanRafique, AshiquePoueymirou, WilliamKirshner, Jessica R.Smith, EricOlson, WilliamLin, JohnThurston, GavinSleeman, Matthew A.Murphy, Andrew J.Yancopoulos, George D.
- [34] Synergistic antitumor effect of bispecific CD19 x CD3 and CD19 x CD16 diabodies in a preclinical model of non-Hodgkin's lymphomaJOURNAL OF IMMUNOLOGY, 2002, 169 (01): : 137 - 144Kipriyanov, SMCochlovius, BSchäfer, HJMoldenhauer, GBähre, ALe Gall, FKnackmuss, SLittle, M
- [35] CD19/CD3 bispecific antibodies induce potent response against chronic lymphocytic leukemia cells ex vivoJOURNAL OF IMMUNOLOGY, 2017, 198 (01):Robinson, Hannah RuthQi, JunpengBaskar, SivasubramanianRader, ChristophWiestner, Adrian
- [36] Affinity tuned XmAb®2+1 GPC3 x CD3 bispecific antibodies demonstrate selective activity in liver cancer models.CANCER RESEARCH, 2021, 81 (13)Nisthal, AlexHassanzadeh-Kiabi, NargessAvery, Kendra N.Rashid, RumanaDiaz, Juan E.Muchhal, Umesh S.Chu, Seung Y.Moore, Gregory L.Bykova, KatrinaDesjarlais, John R.
- [37] PHARMACODYNAMICS OF JNJ-70218902, A TMEFF2 x CD3 BISPECIFIC ANTIBODY, IN CYNOMOLGUS MONKEYJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1411 - A1411Lowenstein, CassandraBasu, SubhasreeRusbuldt, JoshuaVenkataramani, SathyaErnst, RobinJarantow, SteveBrodeur, ScottRubio, DanielJasiprasart, PharaveeYu, MargaretRupnow, BrentRussell, Michael
- [38] A Next-Generation Fc-Bearing CD3-Engaging Bispecific DART® Platform with Extended Pharmacokinetic and Expanded Pharmacologic Window: Expanded CD123 x CD3 and CD19 x CD3 DART MoleculesBLOOD, 2018, 132Bonvini, EzioLa Motte-Mohs, RossHuang, LingLam, Chia-Ying KaoKaufman, ThomasLiu, LiqinAlderson, Ralph F.Stahl, KurtBrown, Jennifer G.Li, HuaSharma, SharadTamura, JamesJohnson, SydMoore, Paul
- [39] Preclinical discovery and initial clinical data of WVT078, a BCMA x CD3 bispecific antibodyLEUKEMIA, 2023, 37 (06) : 1349 - 1360Raab, Marc S.Cohen, Yael C.Schjesvold, FredrikAardalen, KimberlyOka, AdwaitSpencer, AndrewWermke, MartinSouza, Anita D.Kaufman, Jonathan L.Cafro, Anna MariaOcio, Enrique M.Doki, NorikoHenson, KristinTrabucco, GinaCarrion, AnaBender, Florent C.Juif, Pierre-EricFessehatsion, AdonaiFan, LiqiongStonehouse, Jeffrey P.Blankenship, John W.Granda, BrianDe Vita, SerenaLu, Haihui
- [40] A novel dual CAB nectin-4 x CD3 bispecific antibody targeting solid tumorsCANCER RESEARCH, 2023, 83 (07)Lucas, MatthewCugnetti, Ana PaulaLiu, HaizhenXing, CharlesWang, JingMcNeeley, PatriciaWheeler, ChristinaJoyner, SolmarieJohnson, KyrieWoodard, KathrynZhou, WeiChang, CathyFrey, GerhardBoyle, William J.Short, Jay M.